Jove
Visualize
Contact Us

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance.

Journal of the advanced practitioner in oncology·2026
Same author

Diversity, Equity, and Inclusion in Multiple Myeloma: A Call to Action.

Journal of the advanced practitioner in oncology·2025
Same author

A Focus on Relapsed Multiple Myeloma.

Journal of the advanced practitioner in oncology·2022
Same author

Antiemetics: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2020
Same author

Oncology Nurse Practitioner Competencies: Defining Best Practices in the Oncology Setting.

Clinical journal of oncology nursing·2020
Same author

Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.

American journal of hematology·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 15, 2026

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
14:06

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Published on: April 16, 2013

Introduction to B-Cell disorders.

Kimberly Noonan1

  • 1Dana-Farber Cancer Institute, Boston, MA, USA. kimnoonan664@hotmail.com

Clinical Journal of Oncology Nursing
|May 3, 2007
PubMed
Summary

This article reviews B-cell disorders in autoimmune diseases and monoclonal antibody therapies. Understanding B-cell roles and treatment data is crucial for nurses managing patient care.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • B cells are vital in normal immunity, but their role in autoimmune diseases like rheumatoid arthritis is less understood.
  • Lymphoma involves lymphocytes, yet B-cell involvement in specific autoimmune conditions remains unclear.
  • This review focuses on malignant and nonmalignant B-cell disorders.

Purpose of the Study:

  • To provide an overview of malignant and nonmalignant B-cell disorders.
  • To discuss the potential of monoclonal antibodies in treating autoimmune diseases by targeting B cells.
  • To highlight the importance of nurses understanding monoclonal therapy data.

Main Methods:

  • Literature review and synthesis of current research on B-cell disorders.
  • Analysis of data regarding monoclonal antibody efficacy and safety.

More Related Videos

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

Related Experiment Videos

Last Updated: Jul 15, 2026

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
14:06

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Published on: April 16, 2013

Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

  • Discussion of the implications for nursing practice and patient care.
  • Main Results:

    • B cells play a complex role in various autoimmune diseases.
    • Monoclonal antibodies show promise in depleting B cells and modulating immune responses.
    • Interpreting complex therapeutic data is essential for healthcare professionals, particularly nurses.

    Conclusions:

    • Further research is needed to clarify the precise role of B cells in autoimmune pathogenesis.
    • Monoclonal antibody therapy presents a potential treatment avenue for autoimmune conditions.
    • Nurses require enhanced data interpretation skills to effectively manage patients undergoing novel therapies.